In August 2025, the Nasdaq Composite Index continued its upward trend, rising 1.58% for the month. Although it underperformed compared to the S&P 500 and the Dow Jones Industrial Average during the same period, several individual stocks posted significant gains. Among them, Intel (INTC), Applovin (APP), and IDEXX Laboratories (IDXX) stood out as the top three performers, each climbing more than 21% during the month. The key drivers behind their strong performance included favorable policy developments, impressive earnings growth, and rising industry demand.
Intel Surges on Government and SoftBank Investments
Semiconductor giant Intel delivered a strong performance in August, fueled largely by strategic investments from the U.S. government and Japan’s SoftBank Group.
The U.S. government announced it would acquire approximately a 10% equity stake in Intel, aiming to strengthen domestic semiconductor manufacturing capabilities and enhance competitiveness against global rivals such as Taiwan Semiconductor Manufacturing Co. (TSMC). Additionally, SoftBank’s $2 billion investment further bolstered market confidence in Intel’s capacity expansion and technology research and development.
Applovin’s Earnings Soar as Ad-Tech Business Becomes Growth Engine
Mobile advertising technology company Applovin saw its stock price rise significantly in August, driven largely by its outstanding second-quarter financial results. The company reported a 77% year-over-year increase in revenue, reaching $1.26 billion, while net income surged 164% to $820 million. Perhaps even more impressive was its earnings per share (EPS), which nearly tripled to $2.39.
This growth reflects the rapid expansion of its ad-tech business and its enhanced commercialization capabilities, earning strong recognition from the market.
IDEXX Laboratories Raises Full-Year Guidance on Steady Demand in Animal Health Sector
Animal health diagnostics leader IDEXX Laboratories also delivered an exceptional performance in August. The company’s second-quarter revenue increased 11% year-over-year to $1.1 billion, exceeding market expectations. As a result, IDEXX raised its full-year revenue guidance from the previous range of $4.11–4.28 billion to $4.2–4.28 billion. This adjustment was based on sustained demand growth in areas such as pet healthcare and water testing, as well as steady market share gains.
Industry and Market Outlook
Although the Nasdaq’s overall gains in August lagged behind those of the other two major indices, the technology sector still presented structural opportunities. High-growth segments such as semiconductors, advertising technology, and animal health attracted significant capital inflows.
Analysts note that multiple factors—including improved corporate earnings, the deepening application of artificial intelligence technologies, and policy support—are expected to sustain growth momentum among leading companies in these fields.
It is also worth noting that government-linked transactions involving companies like Intel reflect an accelerating global trend toward self-sufficiency in semiconductor production, which may further reshape the competitive landscape of the industry in the future.
